U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Delivery of multiple doses of medications

Patent 5837284 Issued on November 17, 1998. Estimated Expiration Date: Icon_subject July 14, 2017. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Patent References

Formulations providing three distinct releases
Patent #: 4794001
Issued on: 12/27/1988
Inventor: Mehta ,   et al.

Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
Patent #: 5326570
Issued on: 07/05/1994
Inventor: Rudnic, et al.

Delayed, sustained-release propranolol pharmaceutical preparation
Patent #: 5478573
Issued on: 12/26/1995
Inventor: Eichel, deceased, et al.

Immediate release tablet cores of insoluble drugs having sustained-release coating
Patent #: 5500227
Issued on: 03/19/1996
Inventor: Oshlack, et al.

Controlled release formulations coated with aqueous dispersions of acrylic polymers
Patent #: 5639476
Issued on: 06/17/1997
Inventor: Oshlack, et al.

Method of treating pain by administering 24 hour oral opioid formulations Patent #: 5672360
Issued on: 09/30/1997
Inventor: Sackler, et al.

Inventors

Application

No. 892190 filed on 07/14/1997

US Classes:

424/459, Organic coatings424/458, Containing discrete coated particles pellets, granules, or beads424/462, Containing solid synthetic polymers424/468, Sustained or differential release type514/317Additional ring containing

Examiners

Primary: Henley, III, Raymond

Attorney, Agent or Firm

International Classes

A61K 009/56
A61K 009/54
A61K 009/58
A61K 009/22
A61K 031/21

Abstract

Dosage forms for oral administration of a methylphenidate drug are provided. The dosage forms provide a substantially immediate dose of methylphenidate upon ingestion, followed by one or more additional doses at predetermined times. By providing such a drug release profile, the dosage forms eliminate the need for a patient to carry an additional dose for ingestion during the day. The dosage forms and methods provided are useful in administering methylphenidate and pharmaceutically acceptable salts thereof, which generally require one or more doses throughout the day.

Other References

  • PDR, 46th ed. "Ritalin SR" pp. 880-881, 199
PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
PatentsPlus: add to cart
PatentsPlus: add to cartIntelligent turbocharged patent PDFs with marked up images
$18.95more info
 
Sign InRegister
Username  
Password   
forgot password?